Prescribing behaviour in UK primary care: MIMS survey results

MIMS' latest survey reveals the factors influencing prescribing among UK primary care professionals.

MIMS has surveyed the prescribing habits of 254 primary care professionals.
MIMS has surveyed the prescribing habits of 254 primary care professionals.

In this report available exclusively to MIMS corporate subscribers, we present the conclusions of a survey conducted by MIMS to investigate prescribing behaviour in UK primary care.

Based on the responses of 254 primary care prescribers, the report provides insights into their prescribing habits and challenges, drug information needs, and their attitudes towards prescribing new drugs.

MIMS corporate subscribers can access the report using the password provided by email.

View UK prescribing behaviour report
(password required)

To take out a multi-user or domain licence to MIMS and receive the prescribing behaviour report in full, please contact us.

A MIMS corporate subscription offers:

  • Online access to drug information on over 3000 products
  • Latest drug information – updated daily
  • News on changes that affect prescribing
  • Exclusive MIMS drug reference tables for quick look-up, including HRT preparations and antidepressant switching advice
  • At-a-glance summaries of national treatment guidelines
  • Online visual guides to help you identify, compare and recommend suitable devices
  • MIMS Clinics: online prescribing resource centres for key therapy areas
  • Quarterly print issue (available upon request)
  • Annual report on pharmaceutical product trends
Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

Vitamin D3 Supplements

Formulations and indications of colecalciferol preparations.

Avoid gout drug in patients with major cardiovascular conditions, says MHRA

Avoid gout drug in patients with major cardiovascular conditions, says MHRA

Treatment with febuxostat (Adenuric) should be avoided...

Drug shortages - live tracker

Drug shortages - live tracker

Added: Colestid Orange. Use our constantly updated...

Updated bowel disease treatment summaries published by MIMS

Updated bowel disease treatment summaries published by MIMS

Updated quick-reference summaries of the latest NICE...